Navigation Links
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
Date:6/3/2008

is on the planning and execution of late-stage clinical studies focused on regulatory approval. From 2004 to 2006, Dr. Michelson served as Director in the Clinical Oncology Therapeutic Unit at Chiron (now Novartis AG), where he served as Medical Director and as lead clinician for the company's kinase programs. Previously, he was Medical Director, Clinical Development for Cell Therapeutics, where he was responsible for Phase 3 studies of Xyotax(R). Dr. Michelson began his pharmaceutical industry career at Pfizer Global Research and Development (formerly Agouron), from 1998 to 2003, where he led Phase 1 through Phase 3 clinical development programs in oncology. Dr. Michelson has held faculty positions at the University of California, San Diego, and at the University of Louisville, and has been a Principal Investigator for a number of clinical trials. He received both his M.D. and B.A. in Chemistry from the University of Louisville.

Option Award Disclosure

The Compensation Committee of the company's Board of Directors approved an employment commencement grant to Dr. Ketchum of a non-qualified stock option to purchase 150,000 shares of Sunesis common stock, effective June 30, 2008. Options covering 140,000 of these shares were granted without shareholder approval pursuant to Nasdaq Marketplace Rule 4350 (i)(1)(A)(iv) and with the following material terms: (a) an exercise price equal to the fair market value of the company's common stock on June 30, 2008, (b) a term of ten years, and (c) a vesting schedule providing that the option is exercisable as to one-quarter of the total grant on the first anniversary of Dr. Ketchum's date of hire, and one-forty-eighth of the total grant each month thereafter until the grant is fully vested.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the development of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a high
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational ... (OTCQB: ALQA). Alliqua is an emerging biomedical company ... serve the wound care market. , Free report ... Alliqua was restructured with a seasoned management team ... to become a leading provider of wound care ...
(Date:1/14/2014)... January 14, 2014 iLab Solutions, the ... Detwiler as the new Director of Product Strategy. In ... clients as well as iLab sub-teams to guide in ... be to ensure that iLab provides the maximum possible ... advanced, user-friendly, and high-impact solution in the world. ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ... patient safety, clinical outcomes, and medication adherence. , ...
(Date:1/14/2014)... 14, 2014 Kerr Corporation, a leading manufacturer ... additional how-to information about dual arch impressions on its dental ... Arch Impressions,” the blog entry serves up a list of ... a step-by-step demonstration by Dr. David Little as he crafts ... Take 1 Advanced Rigid as the dual arch dental ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Perceptive Informatics (Perceptive), the industry,s leading ... International Corporation (Nasdaq: PRXL ), today ... with 10 million calls placed through its ClinPhone ... seven years in support of clinical trials for ...
... Expanded IIIP Innovation Confidence Index , ... San Francisco, CA (Vocus) January ... by the drop in consumer confidence last year, according to the ... region of the world and released publicly today. , , , ...
... Enables Expanded Biologics CapabilitiesST. LOUIS, Jan. 29 ... SAFC(R), a member of the Sigma-Aldrich(R) group ... that it has commenced operations at its 7,000 ... CA. Located adjacent to the Company,s existing flagship ...
Cached Biology Technology:Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 2Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 3Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 4Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 5Global Confidence in Innovation Holds Despite Economy 2Global Confidence in Innovation Holds Despite Economy 3Global Confidence in Innovation Holds Despite Economy 4SAFC Pharma Augments Assay Development Capabilities 2SAFC Pharma Augments Assay Development Capabilities 3SAFC Pharma Augments Assay Development Capabilities 4
(Date:4/15/2014)... as 2020 how high sea levels will rise into ... including Florida International University scientist Rene Price. , Price ... Florida Coastal Everglades Long-Term Ecological Research (LTER) site, one ... coral reefs to deserts, mountains to salt marshes around ... is one of the most certain consequences of climate ...
(Date:4/15/2014)... Diana Lados, associate professor of mechanical ... founding director of the university,s Integrative Materials ... career achievement awards from leading engineering societies. ... SAE International, a global association of more ... in the automotive, aerospace, and commercial vehicle ...
(Date:4/15/2014)... in visualizing the movement within plants of a ... drought. The achievement will allow researchers to conduct ... plants respond to drought and other environmental stresses ... carbon dioxide, or CO2, concentration., A paper describing ... of the scientific journal eLife and ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 2WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 3WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 4WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 5Biologists develop nanosensors to visualize movements and distribution of plant hormone 2
... of species of woody vines that University of WisconsinMilwaukee ecologist ... the largest has a stalk nearly 20 inches in circumference. ... because it winds itself up to the forest canopy and ... community of trees." Such vines, called lianas, concentrate their ...
... accuracy and oblique imagery offer new possibilities ... and Mortgage/Banking Industries, ROCHESTER, N.Y., Aug. ... of geo-referenced aerial image libraries whose,proprietary technology ... libraries,today announced a powerful new alliance with ...
... Natural selection . . . By examining ... Oak Ridge National Laboratory hope to develop a strategy ... a process known as association mapping, scientists will attempt ... growing in natural populations with the goal being to ...
Cached Biology News:Vine invasion? UWM ecologist looks at coexistence of trees and lianas 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 3Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM) 2Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM) 3Story tips from the US Department of Energy's Oak Ridge National Laboratory, August 2008 2Story tips from the US Department of Energy's Oak Ridge National Laboratory, August 2008 3
... is the industry standard microarray image analysis ... imaging and analysis tools, visualizations, automation capabilities, ... is included with every GenePix scanner, and ... scanners and all types of arrays. A ...
... one mouse-click image analysis software for ... is the solution for high quality ... MicroVigene is empowered with VigeneTechs robust ... regional 2D-curve fitting background correction and ...
... applications not requiring confocal, the BD Pathway ... the Pathway 435. And, the Pathway 415 ... applications require it. High-performance, ... to use the laser autofocus, camera autofocus, ...
... ProXPRESS 2D Proteomic Imaging System, Professional ... Over a Wide Dynamic Range: The ProXPRESS ... sensitive in imaging system for both proteomic ... 2D provides unparalleled flexibility, enabling the use ...
Biology Products: